West Pharmaceutical Services WST Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on the most recent quarter.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's cash ratio?
- West Pharmaceutical Services (WST) reported cash ratio of 0.8× in Q1 2026.
- How has West Pharmaceutical Services's cash ratio changed year-over-year?
- West Pharmaceutical Services's cash ratio increased by 0.8% year-over-year, from 0.8× to 0.8×.
- What is the long-term trend for West Pharmaceutical Services's cash ratio?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's cash ratio has grown at a -5.3% compound annual growth rate (CAGR), from 4.7× to 3.8×.
- What does cash ratio mean?
- How much of its short-term bills the company could pay with cash on hand right now.
- How do you interpret cash ratio?
- A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
- How does cash ratio compare across companies?
- Varies widely by business model and treasury policy; best read against the company's own history.